Plasma MIP-1β levels and skin toxicity in japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinibKIMURA, Hideharu; KASAHARA, Kazuo; SEKIJIMA, Masaru et al.Lung cancer. 2005, Vol 50, Num 3, pp 393-399, issn 0169-5002, 7 p.Article

A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancerKASAHARA, Kazuo; KIMURA, Hideharu; YOSHIMI, Yuzo et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3723-3728, issn 0250-7005, 6 p.Article

Prospective Study Evaluating the Plasma Concentrations of Twenty-six Cytokines and Response to Morphine Treatment in Cancer PatientsMAKIMURA, Chihiro; ARAO, Tokuzo; KOYAMA, Atsuko et al.Anticancer research. 2011, Vol 31, Num 12, pp 4561-4568, issn 0250-7005, 8 p.Article

Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer : Multicenter phase II trialARAYA, Tomoyuki; KASAHARA, Kazuo; NOBATA, Kouichi et al.Lung cancer. 2007, Vol 56, Num 3, pp 371-376, issn 0169-5002, 6 p.Article

Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancerKIMURA, Hideharu; OHIRA, Tatsuo; UCHIDA, Osamu et al.Lung cancer. 2014, Vol 83, Num 3, pp 329-333, issn 0169-5002, 5 p.Article

Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancerZANDER, Dani S; HORIIKE, Atsushi; NISHIO, Makoto et al.Chest. 2007, Vol 131, Num 6, issn 0012-3692, 1619-1620, 1628-1634 [9 p.]Article

Randomized phase II trial of ok-432 in patients with malignant pleural effusion due to non-small cell lung cancerKASAHARA, Kazuo; SHIBATA, Kazuhiro; ISHIURA, Yoshihisa et al.Anticancer research. 2006, Vol 26, Num 2B, pp 1495-1499, issn 0250-7005, 5 p.Article

Clinical Outcomes of Thoracic Radiotherapy for Locally Advanced NSCLC with EGFR Mutations or EML4-ALK RearrangementHAYASHI, Hidetoshi; OKAMOTO, Isamu; KIMURA, Hideharu et al.Anticancer research. 2012, Vol 32, Num 10, pp 4533-4537, issn 0250-7005, 5 p.Article

Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patientsMATSUOKA, Hiromichi; ARAO, Tokuzo; KOYAMA, Atsuko et al.Oncology reports. 2012, Vol 27, Num 5, pp 1393-1399, issn 1021-335X, 7 p.Article

Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non―Small Cell Lung AdenocarcinomaKASAHARA, Kazuo; ARAO, Tokuzo; IKEDA, Norihiko et al.Clinical cancer research (Print). 2010, Vol 16, Num 18, pp 4616-4624, issn 1078-0432, 9 p.Article

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptorKIMURA, Hideharu; SAKAI, Kazuko; ARAO, Tokuzo et al.Cancer science. 2007, Vol 98, Num 8, pp 1275-1280, issn 1347-9032, 6 p.Article

Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancerSONE, Takashi; KASAHARA, Kazuo; KIMURA, Hideharu et al.Cancer. 2007, Vol 109, Num 9, pp 1836-1844, issn 0008-543X, 9 p.Article

High sensitivity detection of Epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patientsKIMURA, Hideharu; FUJIWARA, Yutaka; SONE, Takashi et al.Cancer science. 2006, Vol 97, Num 7, pp 642-648, issn 1347-9032, 7 p.Article